Neuroendocrine biomarkers, allostatic load, and the challenge of measurement: A commentary on Gersten

Social Science and Medicine

Volumn 66, Issue 3, 2008, Pages 525-530

  Loucks, Eric B ^a   Juster, Robert P ^b   Pruessner, Jens C ^b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Allostatic load; Biomarkers; Measurement; Stress

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; HYDROCORTISONE; NORADRENALIN; PRASTERONE SULFATE;

BIOMARKER; ETIOLOGY; MEASUREMENT METHOD; PHYSIOLOGY; STANDARDIZATION;

ALLOSTATIC LOAD; ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; MEASUREMENT; NEUROENDOCRINE SYSTEM; OUTCOME ASSESSMENT; PHYSIOLOGY; STANDARDIZATION; STRESS;

EID: 37249022981     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.09.006     Document Type: Article

References (43)

1. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 15 7 (1998) 539-553
2. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 9491 (2005) 1059-1062
3. Born J., Hansen K., Marshall L., Mölle M., and Fehm H.L. Timing the end of the nocturnal sleep. Nature 397 6714 (1999) 29-30
4. Brosschot J.F., Pieper S., and Thayer J.F. Expanding stress theory: Prolonged activation and perseverative cognition. Psychoneuroendocrinology 30 10 (2005) 1043-1049
5. Butler R.N. Super hype for super hormones. Geriatrics 52 2 (1997) 13-14
6. Chen C.H., Chou F., Tseng Y., and Lee J.N. The prevalence and predictors of postpartum depression (Chinese). Nursing Research (China) 2 (1994) 263-274
7. Cohen S., Kamarck T., and Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior 24 4 (1983) 385-396
8. Cohen S., Kessler R., and Underwood Gordon L. Measuring stress: A guide for health and social scientists (1995), Oxford University Press, New York
9. Crofford L.J., Engleberg N.C., and Demitrack M.A. Neurohormonal perturbations in fibromyalgia. Baillieres Clinical Rheumatology 10 2 (1996) 365-378
10. De Gruttola V.G., Clax P., DeMets D.L., Downing G.J., Ellenberg S.S., Friedman L., et al. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Controlled Clinical Trials 22 5 (2001) 485-502
11. DeLongis A., Folkman S., and Lazarus R.S. The impact of daily stress on health and mood: Psychological and social resources as mediators. Journal of Personality and Social Psychology 54 3 (1988) 486-495
12. Downing, G. (2000). Biomarkers and surrogate endpoints: Clinical research and applications. Proceedings of the NIH-FDA conference 15-16 April 1999, Bethesda, MD, USA. New York: Elsevier.
13. Epstein S. Comment on the effects of aggregation across and within occasions on consistency, specificity, and reliability. Methodika 4 (1990) 95-100
14. Gersten O. Neuroendocrine biomarkers, social relations, and the cumulative costs of stress in Taiwan. Social Science and Medicine 66 (2008) 507-519
15. Glover D.A., Stuber M., and Poland R.E. Allostatic load in women with and without PTSD symptoms. Psychiatry 69 3 (2006) 191-203
16. Grassi G., and Esler M. How to assess sympathetic activity in humans. Journal of Hypertension 17 6 (1999) 719-734
17. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation.
18. Haus E., and Touitou Y. Principles of clinical chronobiology. In: Touitou Y., and Haus E. (Eds). Biologic rhythms in clinical and laboratory medicine (1994), Springer Verlag, Berlin 6-33
19. Heim C., Ehlert U., and Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25 1 (2000) 1-35
20. Holmes T.H., and Rahe R.H. The Social Readjustment Rating Scale. Journal of Psychosomatic Research 11 2 (1967) 213-218
21. Hull A.M. Neuroimaging findings in post-traumatic stress disorder. Systematic review. The British Journal of Psychiatry 181 (2002) 102-110
22. Khorram O. DHEA: A hormone with multiple effects. Current Opinion in Obstetrics Gynecology 8 5 (1996) 351-354
23. Lee I.T., Sheu W.H., Liau Y.J., Lin S.Y., Lee W.J., and Lin C.C. Relationship of stressful life events, anxiety and depression to hyperthyroidism in an Asian population. Hormone Research 60 5 (2003) 247-251
24. McGinn L.K., Asnis G.M., and Rubinson E. Biological and clinical validation of atypical depression. Psychiatry Research 60 2-3 (1996) 191-198
25. Mildvan D. Biomarkers as surrogate endpoints in clinical trials for HIV/AIDS: A model for other diseases?. In: Downing G.J. (Ed). Biomarkers and surrogate endpoints: Clinical research and applications (2000), Elsevier, New York 13-17
26. Millea, P. J., Holloway, R. L. (2000). Treating fibromyalgia. American Family Physician, 62(7), 1575-1582, 1587.
27. Nair K.S., Rizza R.A., O'Brien P., Dhatariya K., Short K.R., Nehra A., et al. DHEA in elderly women and DHEA or testosterone in elderly men. New England Journal of Medicine 355 16 (2006) 1647-1659
28. Nater, U. M., Rohleder, N., Schlotz, W., Ehlert, U., & Kirschbaum, C. (2007). Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology.
29. NIH Biomarker Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 69 3 (2001) 89-95
30. Pruessner J.C., Hellhammer D.H., and Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosomatic Medicine 61 2 (1999) 197-204
31. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., et al. Free cortisol levels after awakening: A reliable biological marker for the assessment of adrenocortical activity. Life Sciences 61 26 (1997) 2539-2549
32. Schulz P., Kirschbaum C., Pruessner J.C., and Hellhammer D.H. Increased free cortisol secretion after awakening in chronically stressed individuals due to work overload. Stress Medicine 14 (1998) 91-97
33. Schulz, P., Schlotz, W. (1999). Trier Inventar zur Erfassung von chronischem Streß (TICS): Skalenkonstruktion und teststatistische Überprüfung. Trier: Universität Trier.
34. Scott L.V., and Dinan T.G. The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis. Functional Neurology 14 1 (1999) 3-11
35. Skevington S.M., Lotfy M., and O'Connell K.A. The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 13 2 (2004) 299-310
36. Stewart J.W., Quitkin F.M., McGrath P.J., and Klein D.F. Defining the boundaries of atypical depression: Evidence from the HPA axis supports course of illness distinctions. Journal of Affective Disorders 86 2-3 (2005) 161-167
37. Stone A.A., Schwartz J.E., Smyth J., Kirschbaum C., Cohen S., Hellhammer D., et al. Individual differences in the diurnal cycle of salivary free cortisol: A replication of flattened cycles for some individuals. Psychoneuroendocrinology 26 3 (2001) 295-306
38. Thomas G., Frenoy N., Legrain S., Sebag Lanoe R., Baulieu E.E., and Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker. Journal of Clinical Endocrinology & Metabologism 79 5 (1994) 1273-1276
39. Wessa M., Rohleder N., Kirschbaum C., and Flor H. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 31 2 (2006) 209-215
40. Xu J., and Zeger S.L. The evaluation of multiple surrogate endpoints. Biometrics 57 1 (2001) 81-87
41. Yehuda R. Psychoneuroendocrinology of post-traumatic stress disorder. Psychiatric Clinics & North American 21 2 (1998) 359-379
42. Yehuda R. Biological factors associated with susceptibility to posttraumatic stress disorder [see comments]. Canadian Journal of Psychiatry 44 1 (1999) 34-39
43. Zeger S.L. Biomarkers as surrogates in clinical research. In: Downing G.J. (Ed). Biomarkers and surrogate endpoints: Clinical research and applications (2000), Elsevier, New York 22-26